Acetaminophen adducts and methods of use thereof
AssigneeBioVentures, LLC
InventorsLaura P. James, Jack Hinson, Dean Roberts, Pritmohinder S. Gill
Life of this patent
Estimating the term…
Loading patent…
AssigneeBioVentures, LLC
InventorsLaura P. James, Jack Hinson, Dean Roberts, Pritmohinder S. Gill
Estimating the term…
The present disclosure relates to acetaminophen protein adducts and methods of diagnosing acetaminophen toxicity using the acetaminophen protein adducts. The present disclosure provides acetaminophen (APAP)-protein adducts and methods of detecting acetaminophen-induced toxicity in a subject using APAP-protein adducts. One aspect of the present disclosure provides an APAP-protein adduct for diagnosing acetaminophen-induced toxicity. According to the present disclosure, the inventors have identified proteins that are modified by N-acetyl-pbenzoquinoneimine (NAPQI) in subjects with acetaminophen-induced toxicity. Non-limiting examples of proteins modified by NAPQI include betaine-homocysteine S-methyltransferase 1, cytoplasmic aspartate aminotransferase, 1,4-alpha-glucan branching enzyme, formimidoyltransferase-cyclodeaminase, and dystrophin.
A method of treating acetaminophen-induced toxicity in a subject in need thereof, the method comprising:
A method of treating acetaminophen-induced toxicity in a subject in need thereof, the method comprising:
Dependencies are inferred from the claim text.